Nuclear Solutions for National Priorities

ORNL is reducing the financial and technical risks of
fission and fusion demonstration and deployment through innovation.

Thanks in part to ORNLโ€™s rich legacy of nuclear R&Dโ€”from early reactor development to the first shipment of a reactor-produced medical isotope nuclear energy and isotopes have become central to Americaโ€™s security, health, and industrial strength. However, today, the nationโ€™s critical nuclear infrastructure is both unique and aging. Deployment of new reactors is slowed by cost and technical uncertainty, and domestic isotope supplies are strained. ORNL is addressing these challenges by delivering nuclear solutions aligned with national priorities, spanning reactors, fuels, and isotopes.

How ORNL is accelerating nuclear energy deployment


The challenge

Large-scale deployment of fission and the accelerated deployment of fusion are hindered due to financial and technical risks.

Our goal

De-risk demonstration and deployment of fusion and fission energy through scientific and technological innovation.

How we deliver

Drive development of a fission/fusion innovation engine, including public private partnerships, that provides solutions and increased confidence for demonstration and deployment.

Accelerate AI-enabled nuclear deployment

  • Leverage AI to accelerate licensing and improve design and operations.
  • Establish an HPC/AI facility and datasets for fusion and fission systems.

Advance nuclear materials and technologies

  • Accelerate design and qualification of advanced materials.
  • Develop and scale up enabling technologies.

Strengthen the nuclear supply chain

  • Enable a vibrant supply chain through advanced manufacturing.
  • Support regional workforce development across the supply chain.

Fusion partnerships that drive development

ORNL has partnered with Type One Energy to develop a world-class highheat flux facility that will enable scientists to evaluate how materials react under extreme conditions in a fusion device. The unique collaboration with industry, academia, and the national labs will be critical to the delivery of commercial fusion.

Isotopes for a healthy, secure, reliable future

The U.S. faces rising demand for isotopes in healthcare, energy, national security, and researchโ€”needs that exceed current supply capabilities. ORNL plays a vital national role by leveraging its unique facilities to produce priority isotopes, including actinium-225 for cancer trials, iridium-192 for industry, and plutonium-238 for deep space exploration, while advancing technologies that strengthen supply resilience and reduce reliance on foreign sources.

Preparing nuclear energy for deployment

Drawing on nearly two decades in the U.S. and international nuclear industry, Gale Hauck is helping ORNL guide the transition from todayโ€™s large light water reactors to the advanced reactor technologies that could define the next era of nuclear energy. Her work connects technical innovation, policy development and industry partnerships to reduce deployment barriers, support microreactor and advanced reactor programs, and help ensure U.S. nuclear technologies can move from research to real-world use.

Yongtao Liu uses autonomous scanning probe microscopy equipment in a laboratory at Oak Ridge National Laboratory.

End-to-end fuel cycles

The new Uranium Science and Technology Center represents a first ofits-kind capability to advance research across the uranium fuel cycle, from mining to final forms. The 7,500-square-foot corridor of 14 modern laboratories helps improve understanding of nonproliferation relevant chemistry and materials science while stewarding the next generation of nonproliferation scientists and engineers.

Explore more of ORNL’s nuclear research